| APC gene analysis in familial adenomatosis polyposis: 3 new mutations in Turkish population | Ahmet Cevdet CEYLAN, Gulay CEYLAN | 373–377 |
| The Need for Respiratory Support in Acute Leukemia: Frequency, Risk Factors and Prognosis | Burak BİLGİN, Yahya BÜYÜKAŞIK | 378–383 |
| Protective Effects of Royal Jelly against Cyclophosphamide-Induced Liver Damage | Mehmet BÜLBÜL, Mustafa DEMİRCİ, Ömer KORKMAZ, Ebru ANNAÇ, Ali TEKÇE | 384–390 |
| Azacitidine-Etoposide-Cytosine Arabinoside Combination Therapy In Older Acute Myeloid Leukemias | Pınar CÖMERT, Hacer Berna AFACAN ÖZTÜRK, Birgül ÖNEÇ, Osman ŞAHİN, Senem MARAL, Murat ALBAYRAK, Çiğdem PALA, Abdulkerim YILDIZ | 391–395 |
| Concordance between needle biopsy and radical prostatectomy specimens in prostatic carcinoma | Cevahir ÖZER, Bermal HASBAY | 396–401 |
| Clinical significance of inflammatory indexes in patients with epithelial ovarian cancer | Mehmet BİLİCİ, Ali YILMAZ, Hatice YILMAZ, Salim BAŞOL TEKİN | 402–409 |
| Evaluation of Antioxidant Capacity in Advanced Non-Small Cell Lung Cancer | Bülent YALÇIN, Burak BİLGİN, Doğan BAYRAM, Muhammed Bülent AKINCI, Mutlu HIZAL, Mehmet Ali SENDUR, Gözde KART BAYRAM, Didem SENER DEDE, Özcan EREL, Salim NEŞELİOĞLU | 422–428 |
| The Evaluation of Peripheral Neuropathy, Daily Life Activities and Quality of Life in Cancer Patients | Gülsüm SACİD, Fatma ARIKAN | 429–440 |
| Evaluatıon Of Sars-Cov-2 Infectıon In Cancer Patıents: Sıngle-Center Experıence From Turkey | İbrahim KARADAĞ, Serdar KARAKAYA, Ayşegül İLHAN GÜLEŞEN, Berna OKSUZOĞLU, Sabahat CEKEN | 441–447 |
| 12-Cycle of Temozolomide Treatment is not Superior To 6-Cycle of Treatment in Glioblastoma Multiforme | Özgür ATEŞ, İbrahim KARADAĞ, Serdar KARAKAYA, Berna OKSUZOĞLU | 448–457 |
| Genetic Alterations In Turkish Patients With Multiple Myeloma: A Single Center Experience | Tuğçe Nur YİĞENOĞLU, Taha BAHSİ, Mehmet BAKIRTAŞ, Merih KIZIL ÇAKAR, Mehmet Sinan DAL, Fevzi ALTUNTAŞ, Haktan Bagis ERDEM | 458–462 |